Latest news
AstraZeneca, CSPC form China biologics manufacturing joint venture - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 20:21:57 GMTAstraZeneca-BMS merger rumours hit dead end: report - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 14:06:57 GMTVital Signs: The rise of BristolZeneca - FirstWord PHARMAFirstWord PHARMA · Tue, 04 Aug 2026 01:41:57 GMTSpotlight On: Will mega-M&A come full circle to further define Pascal Soriot's AstraZeneca? - FirstWord PHARMAFirstWord PHARMA · Mon, 03 Aug 2026 10:56:55 GMTAstraZeneca, BMS reportedly in $400B merger talks - FirstWord PHARMAFirstWord PHARMA · Mon, 03 Aug 2026 04:16:55 GMTFriday Five – Alnylam's quarter-cutting quarter, AstraZeneca's Claudin consolation, Capricor's statistical shock sequel…and more - FirstWord PHARMAFirstWord PHARMA · Fri, 31 Jul 2026 00:51:36 GMTAstraZeneca's Claudin 18.2-targeting ADC passes pivotal gastric cancer test - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 20:25:00 GMTUltomiris miss in rare thrombotic disorder provides another blot on AstraZeneca's copybook - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 15:34:56 GMT